Modern Healthcare

By: Rachel Cohrs

Drugs imported by states under the Trump administration’s importation plan will not be subject to Medicaid rebates, which means they would not set new 340B prices according to CMS guidance released Friday… The savings from drug importation would hinge on how low states could get drug prices and how widely the imported drugs would be distributed, said Georgetown University Research Professor Edwin Park. “Medicaid gets largest discounts besides the [Department of Veterans Affairs], so the question is whether the imported price going to be so low that the states are better off,” Park said

…

Read more here